JP2021508522A - 非侵襲的な慢性疼痛療法のためのデバイス、システム、及び方法 - Google Patents
非侵襲的な慢性疼痛療法のためのデバイス、システム、及び方法 Download PDFInfo
- Publication number
- JP2021508522A JP2021508522A JP2020534936A JP2020534936A JP2021508522A JP 2021508522 A JP2021508522 A JP 2021508522A JP 2020534936 A JP2020534936 A JP 2020534936A JP 2020534936 A JP2020534936 A JP 2020534936A JP 2021508522 A JP2021508522 A JP 2021508522A
- Authority
- JP
- Japan
- Prior art keywords
- treatment
- tms
- pain
- positioning element
- magnetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 83
- 208000002193 Pain Diseases 0.000 title abstract description 182
- 208000000094 Chronic Pain Diseases 0.000 title abstract description 27
- 238000002560 therapeutic procedure Methods 0.000 title description 10
- 238000011282 treatment Methods 0.000 claims description 348
- 230000005291 magnetic effect Effects 0.000 claims description 166
- 230000001225 therapeutic effect Effects 0.000 claims description 94
- 230000033001 locomotion Effects 0.000 claims description 58
- 238000003384 imaging method Methods 0.000 claims description 52
- 230000000638 stimulation Effects 0.000 claims description 44
- 230000004907 flux Effects 0.000 claims description 29
- 238000012384 transportation and delivery Methods 0.000 claims description 21
- 238000004891 communication Methods 0.000 claims description 16
- 230000008569 process Effects 0.000 claims description 13
- 230000008058 pain sensation Effects 0.000 abstract description 18
- 210000000578 peripheral nerve Anatomy 0.000 abstract description 8
- 208000028389 Nerve injury Diseases 0.000 abstract description 4
- 230000008764 nerve damage Effects 0.000 abstract description 4
- 208000004296 neuralgia Diseases 0.000 abstract description 4
- 201000001119 neuropathy Diseases 0.000 abstract description 4
- 230000007823 neuropathy Effects 0.000 abstract description 4
- 208000033808 peripheral neuropathy Diseases 0.000 abstract description 4
- 230000000472 traumatic effect Effects 0.000 abstract description 4
- 238000010586 diagram Methods 0.000 abstract 1
- 238000011491 transcranial magnetic stimulation Methods 0.000 description 205
- 230000036407 pain Effects 0.000 description 139
- 210000005036 nerve Anatomy 0.000 description 42
- 230000008685 targeting Effects 0.000 description 34
- 210000004126 nerve fiber Anatomy 0.000 description 32
- 230000000694 effects Effects 0.000 description 29
- 230000006378 damage Effects 0.000 description 20
- 230000006698 induction Effects 0.000 description 20
- 230000007246 mechanism Effects 0.000 description 20
- 210000002569 neuron Anatomy 0.000 description 20
- 230000004044 response Effects 0.000 description 19
- 238000004458 analytical method Methods 0.000 description 17
- 230000006870 function Effects 0.000 description 17
- 210000001170 unmyelinated nerve fiber Anatomy 0.000 description 14
- 238000005259 measurement Methods 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 230000009467 reduction Effects 0.000 description 12
- 230000009471 action Effects 0.000 description 11
- 208000005298 acute pain Diseases 0.000 description 11
- 208000014674 injury Diseases 0.000 description 11
- 238000007726 management method Methods 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 11
- 230000013016 learning Effects 0.000 description 10
- 239000003550 marker Substances 0.000 description 10
- 239000011159 matrix material Substances 0.000 description 10
- 230000004936 stimulating effect Effects 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 238000013473 artificial intelligence Methods 0.000 description 9
- 239000000835 fiber Substances 0.000 description 9
- 238000011369 optimal treatment Methods 0.000 description 9
- 238000012549 training Methods 0.000 description 9
- 238000011269 treatment regimen Methods 0.000 description 9
- 230000004913 activation Effects 0.000 description 8
- 230000001276 controlling effect Effects 0.000 description 8
- 230000001537 neural effect Effects 0.000 description 8
- 230000002093 peripheral effect Effects 0.000 description 8
- 238000012545 processing Methods 0.000 description 8
- 230000001953 sensory effect Effects 0.000 description 8
- 230000011664 signaling Effects 0.000 description 8
- 239000000730 antalgic agent Substances 0.000 description 7
- 210000004556 brain Anatomy 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 230000001154 acute effect Effects 0.000 description 6
- 229940035676 analgesics Drugs 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 230000018109 developmental process Effects 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 230000008052 pain pathway Effects 0.000 description 6
- 210000003594 spinal ganglia Anatomy 0.000 description 6
- 206010049119 Emotional distress Diseases 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000005540 biological transmission Effects 0.000 description 5
- 210000003169 central nervous system Anatomy 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000007383 nerve stimulation Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 230000004043 responsiveness Effects 0.000 description 5
- 230000035807 sensation Effects 0.000 description 5
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 4
- 239000008186 active pharmaceutical agent Substances 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 230000003292 diminished effect Effects 0.000 description 4
- 230000005670 electromagnetic radiation Effects 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 238000012804 iterative process Methods 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 230000015654 memory Effects 0.000 description 4
- 230000003040 nociceptive effect Effects 0.000 description 4
- 229940005483 opioid analgesics Drugs 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000004404 Intractable Pain Diseases 0.000 description 3
- 208000012902 Nervous system disease Diseases 0.000 description 3
- 208000025966 Neurological disease Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000009429 distress Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 238000011221 initial treatment Methods 0.000 description 3
- 210000000944 nerve tissue Anatomy 0.000 description 3
- 210000000653 nervous system Anatomy 0.000 description 3
- 210000000929 nociceptor Anatomy 0.000 description 3
- 108091008700 nociceptors Proteins 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 230000008050 pain signaling Effects 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 208000020401 Depressive disease Diseases 0.000 description 2
- 206010013654 Drug abuse Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000026251 Opioid-Related disease Diseases 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 210000003050 axon Anatomy 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000008275 binding mechanism Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000003990 capacitor Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 238000013523 data management Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 238000002635 electroconvulsive therapy Methods 0.000 description 2
- 238000004146 energy storage Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000013632 homeostatic process Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 239000000976 ink Substances 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 210000003007 myelin sheath Anatomy 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 201000000988 opioid abuse Diseases 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 238000013021 overheating Methods 0.000 description 2
- 229960005489 paracetamol Drugs 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 210000001428 peripheral nervous system Anatomy 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 210000000278 spinal cord Anatomy 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 210000001186 vagus nerve Anatomy 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 1
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 1
- 206010006550 Bulimia nervosa Diseases 0.000 description 1
- 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 description 1
- 102100025588 Calcitonin gene-related peptide 1 Human genes 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010064012 Central pain syndrome Diseases 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 208000014094 Dystonic disease Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000004454 Hyperalgesia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 208000005890 Neuroma Diseases 0.000 description 1
- 108090000189 Neuropeptides Proteins 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- -1 TNFα Chemical class 0.000 description 1
- 208000030886 Traumatic Brain injury Diseases 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 206010053552 allodynia Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010205 computational analysis Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 230000009133 cooperative interaction Effects 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000005289 dietary characteristics Nutrition 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000010118 dystonia Diseases 0.000 description 1
- 230000005674 electromagnetic induction Effects 0.000 description 1
- 201000006517 essential tremor Diseases 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000005294 ferromagnetic effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 108091008708 free nerve endings Proteins 0.000 description 1
- 238000002599 functional magnetic resonance imaging Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000001932 glossopharyngeal nerve Anatomy 0.000 description 1
- 229910021389 graphene Inorganic materials 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000003284 homeostatic effect Effects 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 150000002500 ions Chemical group 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- 238000010801 machine learning Methods 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 238000002653 magnetic therapy Methods 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 210000000337 motor cortex Anatomy 0.000 description 1
- 229910000595 mu-metal Inorganic materials 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000003666 myelinated nerve fiber Anatomy 0.000 description 1
- 230000023105 myelination Effects 0.000 description 1
- 208000019382 nerve compression syndrome Diseases 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 230000003955 neuronal function Effects 0.000 description 1
- 208000021722 neuropathic pain Diseases 0.000 description 1
- 229940121367 non-opioid analgesics Drugs 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940124636 opioid drug Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 230000037324 pain perception Effects 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 229910000889 permalloy Inorganic materials 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 210000002243 primary neuron Anatomy 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000009023 proprioceptive sensation Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000003488 releasing hormone Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 231100000812 repeated exposure Toxicity 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 238000013468 resource allocation Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000001032 spinal nerve Anatomy 0.000 description 1
- 210000000273 spinal nerve root Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009529 traumatic brain injury Effects 0.000 description 1
- 210000003901 trigeminal nerve Anatomy 0.000 description 1
- 238000013024 troubleshooting Methods 0.000 description 1
- 230000001515 vagal effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
- A61N2/008—Magnetotherapy specially adapted for a specific therapy for pain treatment or analgesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/20—Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/25—User interfaces for surgical systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/30—Surgical robots
- A61B34/32—Surgical robots operating autonomously
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/20—Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
- A61B2034/2046—Tracking techniques
- A61B2034/2048—Tracking techniques using an accelerometer or inertia sensor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/20—Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
- A61B2034/2046—Tracking techniques
- A61B2034/2055—Optical tracking systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/20—Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
- A61B2034/2046—Tracking techniques
- A61B2034/2055—Optical tracking systems
- A61B2034/2057—Details of tracking cameras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/25—User interfaces for surgical systems
- A61B2034/254—User interfaces for surgical systems being adapted depending on the stage of the surgical procedure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/25—User interfaces for surgical systems
- A61B2034/256—User interfaces for surgical systems having a database of accessory information, e.g. including context sensitive help or scientific articles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/25—User interfaces for surgical systems
- A61B2034/258—User interfaces for surgical systems providing specific settings for specific users
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/06—Measuring instruments not otherwise provided for
- A61B2090/064—Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/06—Measuring instruments not otherwise provided for
- A61B2090/064—Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension
- A61B2090/066—Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension for measuring torque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/30—Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure
- A61B2090/309—Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure using white LEDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
- A61B2090/371—Surgical systems with images on a monitor during operation with simultaneous use of two cameras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3937—Visible markers
- A61B2090/3941—Photoluminescent markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3937—Visible markers
- A61B2090/395—Visible markers with marking agent for marking skin or other tissue
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Robotics (AREA)
- Radiology & Medical Imaging (AREA)
- Human Computer Interaction (AREA)
- Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Magnetic Treatment Devices (AREA)
Abstract
【選択図】図1A
Description
本願は、その開示が参照によりその全体として本明細書に援用される、「Systems and Methods for Non−Invasive Chronic Pain Therapy」と題する2017年12月21日に出願された米国仮特許出願第62/609,330号の利益を主張する。
Claims (20)
- 経皮的磁気刺激(tMS)を対象者の体の上の治療部位に送達するためのシステムであって、
前記対象者の前記体に近接して位置決めされるときに前記治療部位に集束磁束を送達するために構成されたtMSデバイスであって、
拡張された本体を有する筐体であって、前記拡張された本体が、近接端部を有する近接部分及び遠位端を有する遠位部分を含み、前記拡張された本体が前記tMSデバイスの1つ以上の構成要素を保持するための空洞を画定する、前記筐体と、
前記筐体の前記拡張された本体の前記近接部分内に配置される絶縁された磁気コイルであって、集束磁束を生成し、決定されたパルス繰り返し数で送達するために構成された前記磁気コイルと、
前記磁気コイルと通信する制御モジュールであって、前記対象者の前記治療部位にtMSを送達するために前記tMSデバイスの前記磁気コイルにより送達される前記集束磁束及び前記パルス繰り返し数を制御するように構成された前記制御モジュールと
を備える前記tMSデバイスと、
近接端部を含む近接部分及び遠位端を含む遠位部分を有する位置決め要素であって、前記遠位部分が前記遠位端に近接して前記磁気コイルに結合され、前記位置決め要素が複数の関節接合アーム部材から構成され、複数の前記アーム部材が自動化要素により互いに結合され、前記自動化要素が前記治療部位に近接する前記tMSデバイスの前記位置決めを支援するためである、前記位置決め要素と、
撮像構成要素であって、前記撮像構成要素が1つ以上の画像取込みデバイスを含み、各画像取込みデバイスが3次元空間を画定する1つ以上の画像を取り込むために構成され、前記3次元空間が前記対象者、前記tMSデバイス、及び前記位置決め要素の1つ以上により占有される、前記撮像構成要素と、
前記tMSデバイスの前記筐体に結合された距離スキャナであって、前記磁気コイルと治療される前記対象者の前記体の上の前記治療部位との間の距離を決定するために構成される前記距離スキャナと、
前記治療部位に近接して位置決めされるための反射マーキングデバイスであって、前記距離スキャナが前記磁気コイルと前記治療部位との間の前記距離を決定できるようにするほど十分に前記距離スキャナから発せられる光を反射するために構成された複数の反射素子を含む前記反射マーキングデバイスと、
前記近位端の近くで前記位置決め要素の前記近位部分に結合された制御モジュールであって、前記tMSデバイス、前記位置決め要素、前記撮像構成要素、及び前記距離スキャナの1つ以上を制御するために構成される前記制御モジュールと
を備える、システム。 - 前記tMSデバイスの前記磁気コイルが複数のコイルをさらに備え、前記複数のコイルが前記複数のコイル間に磁場を生成するように配置され、前記生成された磁場が、いずれかのコイルが独力で個別に生成できるであろう磁場の振幅よりも大きい振幅を有する、請求項1に記載のシステム。
- 前記tMSデバイスにより生成された前記磁束の前記決定されたパルス繰り返し数が、約0.2Hz〜約5Hzの範囲内の周波数を有する、請求項2に記載のシステム。
- 前記自動化要素が1つ以上のモータを備え、前記1つ以上のモータが、x平面、y平面、及びz平面の1つ以上に沿った移動を提供するために構成される、請求項1に記載のシステム。
- 前記1つ以上のモータが、x軸、y軸、及びz軸の1つ以上に沿った移動を提供するために構成される、請求項4に記載のシステム。
- 前記位置決め要素がロボットアームを備える、請求項5に記載のシステム。
- 前記制御モジュールが、前記ロボットアームが自律的に移動するように前記ロボットアームの前記1つ以上のモータを制御するように構成される、請求項6に記載のシステム。
- 前記撮像構成要素がカメラを備える、請求項7に記載のシステム。
- 前記カメラが立体カメラを備える、請求項8に記載のシステム。
- 前記距離スキャナがレーザーを備える、請求項9に記載のシステム。
- 前記立体カメラ及び前記距離スキャナがともに前記磁気コイルを前記治療部位に関して追跡し、整列させるために構成される、請求項10に記載のシステム。
- 前記追跡及び整列が、前記対象者のいかなる移動にも関わらず、前記磁気コイルと前記治療部位との間の最適距離を維持するためにリアルタイムで実行される、請求項11に記載のシステム。
- 前記反射マーキングデバイスが複数の対向する拡張されたアーム部材を備え、各アーム部材が近位端を有する近位部分及び遠位端を有する遠位部分を含み、前記アーム部材が前記アーム部材の近位端で互いに結合され、前記反射マーキングデバイスが、各アーム部材の前記遠位端に近接して位置決めされた反射素子を含む、請求項12に記載のシステム。
- 前記ロボットアームの前記アーム部材の1つ以上が反射素子を備え、前記反射素子が前記3次元空間を通して前記ロボットアームの前記追跡を容易にする、請求項13に記載のシステム。
- 前記位置決め要素が、前記ロボットアーム又は前記磁気コイルの1つ以上を後退させるために構成された圧力センサを備える、請求項14に記載のシステム。
- 前記圧力センサがトルク力センサを備える、請求項15に記載のシステム。
- 前記システムが、データベースに結合されたクラウドベースのサーバをさらに備え、前記クラウドベースのサーバが結果データを生成するように画像データを処理するために構成され、前記データベースが前記画像データ及び前記結果データの1つ以上を記憶するためである、請求項16に記載のシステム。
- 前記制御モジュールが、ネットワーク接続を介して、前記制御モジュールが前記クラウドベースのサーバと通信できるようにするために構成された通信モジュールを備える、請求項17に記載のシステム。
- 前記制御モジュールが1つ以上の指示を実施するために構成され、前記1つ以上の指示が、前記治療部位へのtMSの前記送達のための最適配置で前記tMSデバイスを位置決めすることに関する、請求項18に記載のシステム。
- 前記制御モジュールが、前記システムのグラフィックユーザインタフェースを表示するための制御デバイスを含む、請求項19に記載のシステム。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762609330P | 2017-12-21 | 2017-12-21 | |
US62/609,330 | 2017-12-21 | ||
PCT/US2018/067369 WO2019126792A1 (en) | 2017-12-21 | 2018-12-21 | Devices, systems, and methods for non-invasive chronic pain therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2021508522A true JP2021508522A (ja) | 2021-03-11 |
Family
ID=66949218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020534936A Pending JP2021508522A (ja) | 2017-12-21 | 2018-12-21 | 非侵襲的な慢性疼痛療法のためのデバイス、システム、及び方法 |
Country Status (6)
Country | Link |
---|---|
US (2) | US11058887B2 (ja) |
EP (1) | EP3727581B1 (ja) |
JP (1) | JP2021508522A (ja) |
CN (1) | CN112105416A (ja) |
AU (1) | AU2018389324A1 (ja) |
WO (1) | WO2019126792A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7498873B2 (ja) | 2022-09-07 | 2024-06-12 | 河南理行合医療科技有限公司 | マイクロ波理学療法の鍼治療器及びその使用方法 |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11004563B2 (en) * | 2018-05-22 | 2021-05-11 | International Business Machines Corporation | Adaptive pain management and reduction based on monitoring user conditions |
CN109260593B (zh) * | 2018-09-27 | 2020-09-08 | 武汉资联虹康科技股份有限公司 | 一种经颅磁刺激治疗方法及设备 |
EP3721939B1 (en) | 2019-04-11 | 2022-07-06 | BTL Healthcare Technologies a.s. | Device for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
US11305130B2 (en) | 2019-07-03 | 2022-04-19 | NeuraLace Medical, Inc. | Devices, systems, and methods for non-invasive chronic pain therapy |
KR20220034831A (ko) * | 2019-07-11 | 2022-03-18 | 더 유나이티드 스테이츠 거번먼트 애즈 리프리젠티드 바이 더 디파트먼트 오브 베테랑스 어페어즈 | 경두개 자기 자극 코일 정렬 장치 |
US11923088B2 (en) * | 2019-08-30 | 2024-03-05 | AR & NS Investment, LLC | Artificial intelligence-based personalized health maintenance system to generate digital therapeutic environment for multi-modal therapy |
CN110639127A (zh) * | 2019-09-26 | 2020-01-03 | 深圳英智科技有限公司 | 一种经颅磁刺激系统 |
US11878167B2 (en) | 2020-05-04 | 2024-01-23 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
US12089910B2 (en) * | 2020-05-28 | 2024-09-17 | The Chinese University Of Hong Kong | Mobile-electromagnetic coil-based magnetic actuation systems |
FI130569B (en) * | 2021-03-15 | 2023-11-21 | Nexstim Oyj | System and method for assisting in the delivery of transcranial magnetic stimulation |
CN113128592B (zh) * | 2021-04-20 | 2022-10-18 | 重庆邮电大学 | 一种用于异构的医疗器械标识解析方法、系统及存储介质 |
US20230018739A1 (en) * | 2021-07-16 | 2023-01-19 | Synerfuse, Inc. | Robotic navigation and guidance system for implanting a neuromodulation device |
CN113633895A (zh) * | 2021-08-03 | 2021-11-12 | 刘木清 | 一种用于减轻原发性痛经的光疗装置 |
US11758263B2 (en) * | 2021-08-24 | 2023-09-12 | Moleculight, Inc. | Systems, devices, and methods for imaging and measurement using a stereoscopic camera system |
EP4415812A1 (en) | 2021-10-13 | 2024-08-21 | BTL Medical Solutions a.s. | Devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
CN117838303B (zh) * | 2024-01-31 | 2024-08-02 | 中山大学附属第五医院 | 一种疼痛治疗仪器的辅助装置和系统 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050113630A1 (en) * | 2001-05-04 | 2005-05-26 | Peter Fox | Apparatus and methods for delivery of transcranial magnetic stimulation |
US20080064950A1 (en) * | 2006-09-13 | 2008-03-13 | Jarmo Ruohonen | Method and Apparatus for Correcting an Error in the Co-Registration of Coordinate Systems Used to Represent Objects Displayed During Navigated Brain Stimulation |
US20130345491A1 (en) * | 2011-03-09 | 2013-12-26 | A School Corporation Kansai University | Image data processing device and transcranial magnetic stimulation apparatus |
JP3188759U (ja) * | 2012-11-23 | 2014-02-06 | ネクスティム オーワイ | 頭部トラッキングユニット |
US20140343351A1 (en) * | 2011-10-24 | 2014-11-20 | Teijin Pharma Limited | Transcranial magnetic stimulation system |
US20160015995A1 (en) * | 2013-03-11 | 2016-01-21 | The Regents Of The University Of California | Portable transcutaneous magnetic stimulator and systems and methods of use thereof |
JP2017176534A (ja) * | 2016-03-30 | 2017-10-05 | ソニー株式会社 | 圧排子及び圧排装置 |
US20170296838A1 (en) * | 2014-10-07 | 2017-10-19 | Teijin Pharma Limited | Transcranial magnetic stimulation system |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6505A (en) | 1849-06-05 | Smut-machine | ||
US75A (en) | 1836-11-08 | Opening- and closing safety-valves of steam-boilers | ||
US5263480A (en) | 1991-02-01 | 1993-11-23 | Cyberonics, Inc. | Treatment of eating disorders by nerve stimulation |
US5299569A (en) | 1991-05-03 | 1994-04-05 | Cyberonics, Inc. | Treatment of neuropsychiatric disorders by nerve stimulation |
US5470846A (en) | 1994-01-14 | 1995-11-28 | Sandyk; Reuven | Treatment of neurological and mental disorders |
US5540734A (en) | 1994-09-28 | 1996-07-30 | Zabara; Jacob | Cranial nerve stimulation treatments using neurocybernetic prosthesis |
US6505075B1 (en) | 1999-05-29 | 2003-01-07 | Richard L. Weiner | Peripheral nerve stimulation method |
US7520848B2 (en) * | 2004-04-09 | 2009-04-21 | The Board Of Trustees Of The Leland Stanford Junior University | Robotic apparatus for targeting and producing deep, focused transcranial magnetic stimulation |
US8177702B2 (en) * | 2004-04-15 | 2012-05-15 | Neuronetics, Inc. | Method and apparatus for determining the proximity of a TMS coil to a subject's head |
US8088058B2 (en) * | 2005-01-20 | 2012-01-03 | Neuronetics, Inc. | Articulating arm |
US7894905B2 (en) * | 2006-03-13 | 2011-02-22 | Neuropace, Inc. | Implantable system enabling responsive therapy for pain |
US20100185042A1 (en) * | 2007-08-05 | 2010-07-22 | Schneider M Bret | Control and coordination of transcranial magnetic stimulation electromagnets for modulation of deep brain targets |
JP2013508119A (ja) * | 2009-10-26 | 2013-03-07 | エムキネティクス, インコーポレイテッド | 神経、筋肉および身体組織の電磁刺激のための方法および装置 |
TW201211004A (en) * | 2010-03-16 | 2012-03-16 | Tosoh Corp | 1,2,4,5-substituted phenyl derivative and production method thereof, and organic electroluminescent element using the same derivative as constituent |
CN103249451A (zh) * | 2010-11-16 | 2013-08-14 | 朱赛佩·马里奥 | 用于快速抑制神经性的,肿瘤的,以及儿科的疼痛的,抵抗麻醉剂以及传统电针镇痛的装置和方法 |
US9265965B2 (en) * | 2011-09-30 | 2016-02-23 | Board Of Regents, The University Of Texas System | Apparatus and method for delivery of transcranial magnetic stimulation using biological feedback to a robotic arm |
WO2015142922A1 (en) * | 2014-03-17 | 2015-09-24 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | System with an electromagnetic field generator with coils for treating tumors and a method for treating tissue |
CA2857555A1 (en) * | 2014-04-01 | 2015-10-01 | William F. Stubbeman | Method and system for therapeutic brain stimulation using electromagnetic pulses |
BR112017004062A2 (pt) * | 2014-08-26 | 2017-12-05 | Avent Inc | sistema e método para identificação de um via neural associada a dor crônica através da estimulação nervosa e monitoramento de ondas cerebrais |
EP3278838B1 (en) * | 2015-04-03 | 2021-10-20 | The University of Tokyo | Coil apparatus for use in transcranial magnetic stimulation apparatus |
EP3441113A4 (en) * | 2016-04-06 | 2019-11-06 | Teijin Pharma Limited | TRANSCRANIAL MAGNETIC STIMULATION SYSTEM AND POSITIONING ASSISTANCE METHOD AND PROGRAM |
-
2018
- 2018-12-21 JP JP2020534936A patent/JP2021508522A/ja active Pending
- 2018-12-21 WO PCT/US2018/067369 patent/WO2019126792A1/en unknown
- 2018-12-21 US US16/231,249 patent/US11058887B2/en active Active
- 2018-12-21 EP EP18892465.8A patent/EP3727581B1/en active Active
- 2018-12-21 AU AU2018389324A patent/AU2018389324A1/en active Pending
- 2018-12-21 CN CN201880090085.3A patent/CN112105416A/zh active Pending
-
2021
- 2021-06-07 US US17/341,143 patent/US20210290969A1/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050113630A1 (en) * | 2001-05-04 | 2005-05-26 | Peter Fox | Apparatus and methods for delivery of transcranial magnetic stimulation |
US20080064950A1 (en) * | 2006-09-13 | 2008-03-13 | Jarmo Ruohonen | Method and Apparatus for Correcting an Error in the Co-Registration of Coordinate Systems Used to Represent Objects Displayed During Navigated Brain Stimulation |
US20130345491A1 (en) * | 2011-03-09 | 2013-12-26 | A School Corporation Kansai University | Image data processing device and transcranial magnetic stimulation apparatus |
US20140343351A1 (en) * | 2011-10-24 | 2014-11-20 | Teijin Pharma Limited | Transcranial magnetic stimulation system |
JP3188759U (ja) * | 2012-11-23 | 2014-02-06 | ネクスティム オーワイ | 頭部トラッキングユニット |
US20160015995A1 (en) * | 2013-03-11 | 2016-01-21 | The Regents Of The University Of California | Portable transcutaneous magnetic stimulator and systems and methods of use thereof |
US20170296838A1 (en) * | 2014-10-07 | 2017-10-19 | Teijin Pharma Limited | Transcranial magnetic stimulation system |
JP2017176534A (ja) * | 2016-03-30 | 2017-10-05 | ソニー株式会社 | 圧排子及び圧排装置 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7498873B2 (ja) | 2022-09-07 | 2024-06-12 | 河南理行合医療科技有限公司 | マイクロ波理学療法の鍼治療器及びその使用方法 |
Also Published As
Publication number | Publication date |
---|---|
WO2019126792A1 (en) | 2019-06-27 |
US11058887B2 (en) | 2021-07-13 |
US20190192874A1 (en) | 2019-06-27 |
EP3727581A4 (en) | 2021-09-22 |
EP3727581B1 (en) | 2023-10-25 |
CN112105416A (zh) | 2020-12-18 |
AU2018389324A1 (en) | 2020-08-06 |
EP3727581A1 (en) | 2020-10-28 |
US20210290969A1 (en) | 2021-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2021508522A (ja) | 非侵襲的な慢性疼痛療法のためのデバイス、システム、及び方法 | |
US11126270B2 (en) | Systems and methods for mitigating gesture input error | |
US10369373B2 (en) | Portable transcutaneous magnetic stimulator and systems and methods of use thereof | |
CA2734992C (en) | Systems and methods for providing a magnetic resonance treatment to a subject | |
US11347316B2 (en) | Systems and methods for mitigating gesture input error | |
US11305130B2 (en) | Devices, systems, and methods for non-invasive chronic pain therapy | |
CA3185886A1 (en) | Wearable neurostimulation system with curated therapy | |
US20170281938A1 (en) | Topical Nerve Stimulator and Sensor for Bladder Control | |
US20220323766A1 (en) | Systems and methods for providing neurostimulation therapy according to machine learning operations | |
US20210196565A1 (en) | Devices, systems and methods for auricular acupuncture | |
WO2006015002A1 (en) | Biological interface system with clinician confirmation of parameter changes | |
US10188869B2 (en) | Hardware/software integrated design for a 3D tremor detector using TMS in Parkinson's disease and related disorders | |
CN116936060A (zh) | 医疗系统的故障检测方法及相关装置 | |
US20190275332A1 (en) | Interactive Virtual Assistant System and Method for Neural Stimulation Therapy | |
US20170239471A1 (en) | Topical Nerve Stimulator and Sensor for Pain Management | |
US20200297992A1 (en) | Primary Dysmenorrhea Pain Reduction | |
KR102702376B1 (ko) | 개인맞춤형 뇌 자극 디바이스 | |
CN118571453A (zh) | 植入式设备的远程控制方法及相关设备 | |
CN116825317A (zh) | 程控配对方法、电子设备、存储介质及程序产品 | |
CN117599337A (zh) | 远程神经监控系统及使用方法 | |
WO2023069940A1 (en) | Systems and methods for providing neurostimulation therapy using multi-dimensional patient features | |
CN116779132A (zh) | 远程程控方法、程控设备、存储介质及程序产品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20211220 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220111 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20221223 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221227 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230323 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20230725 |